Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001076809-25-000052·Drugs Made In America Acquisition Corp.
Schedule 13G ownership disclosure
DRUGS MADE IN AMER ACQUTN CO
Ordinary Shares · CUSIP: G2847J104
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Glazer Capital, LLC
Shares: 1,822,952.00 · Class: 5.44%
- Paul J. Glazer
Shares: 1,822,952.00 · Class: 5.44%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001076809-25-000052
- Form type
- SCHEDULE 13G
- Filer
- Drugs Made In America Acquisition Corp.
- CIK
- CIK 2028614
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership